Parenteral use of recombinant   activated factor VII during   diffuse alveolar hemorrhage   secondary to leptospirosis.
Tatopoulos
Alexis
A
Herbain
Delphine
D
Kazmierczak
Céline
C
Bollaert
Pierre-Edouard
PE
Gibot
Sébastien
S
D015942:Factor VIIa / Q000494:pharmacology / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007922:Leptospirosis / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011295:Prenatal Care; D011650:Pulmonary Alveoli / Q000503:physiopathology*; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D015898:Tomography Scanners, X-Ray Computed; D016896:Treatment Outcome
D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa